We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

118 hedge funds and large institutions have $814M invested in Dr. Reddy's Laboratories in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 41

7.7% less ownership

Funds ownership: 76.25% → 68.55% (-7.7%)

8% less funds holding

Funds holding: 128 → 118 (-10)

24% less capital invested

Capital invested by funds: $1.07B → $814M (-$251M)

41% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 22

71% less call options, than puts

Call options by funds: $1.95M | Put options by funds: $6.6M

Holders
118
Holders Change
-10
Holders Change %
-7.81%
% of All Funds
2.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
42
Reduced
41
Closed
22
Calls
$1.95M
Puts
$6.6M
Net Calls
-$4.66M
Net Calls Change
-$4.58M

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$12.1M
2
BlackRock
BlackRock
New York
+$6.77M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$5.51M
4
Jane Street
Jane Street
New York
+$3.77M
5
Citigroup
Citigroup
New York
+$3.56M

Top Sellers

1
CBOA
Commonwealth Bank of Australia
Australia
-$48.4M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$22.5M
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$10.2M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.71M
5
LP
LMR Partners
United Kingdom
-$7.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
26
Prudential Financial
New Jersey
$3.79M -$2.8M -390,000 -42%
Legal & General Group
27
Legal & General Group
United Kingdom
$3.76M -$212K -29,500 -5%
Jane Street
28
Jane Street
New York
$3.74M +$3.77M +524,495 New
Swiss National Bank
29
Swiss National Bank
Switzerland
$3.72M – – –
Aviva
30
Aviva
United Kingdom
$3.65M +$1.01M +140,000 +38%
Renaissance Technologies
31
Renaissance Technologies
New York
$3.63M -$6.58M -914,500 -64%
State of New Jersey Common Pension Fund D
32
State of New Jersey Common Pension Fund D
New Jersey
$3.52M – – –
CCM
33
Causeway Capital Management
California
$3.43M -$3.33M -462,500 -49%
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$3.29M -$1.17M -163,245 -26%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$2.65M -$759K -105,615 -22%
H
36
Hexavest
Quebec, Canada
$2.64M +$2.03M +282,610 +323%
PHAM
37
Portland Hill Asset Management
United Kingdom
$2.04M -$205K -28,445 -9%
Goldman Sachs
38
Goldman Sachs
New York
$2.03M -$56.8K -7,905 -3%
Envestnet Asset Management
39
Envestnet Asset Management
Illinois
$2.02M +$213K +29,660 +12%
UCFA
40
United Capital Financial Advisors
Texas
$2.02M +$212K +29,515 +12%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$1.95M +$1.97M +273,805 New
SGH
42
Sivik Global Healthcare
Connecticut
$1.78M +$1.8M +250,000 New
Geode Capital Management
43
Geode Capital Management
Massachusetts
$1.72M – – –
SAM
44
Sectoral Asset Management
Quebec, Canada
$1.63M +$961K +133,655 +140%
Nomura Holdings
45
Nomura Holdings
Japan
$1.44M – – –
Nordea Investment Management
46
Nordea Investment Management
Sweden
$1.25M – – –
Bank of New York Mellon
47
Bank of New York Mellon
New York
$1.21M +$199K +27,705 +20%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$1.17M – – –
HCM
49
Highbridge Capital Management
New York
$1.07M +$1.08M +150,000 New
BNP Paribas Asset Management
50
BNP Paribas Asset Management
France
$1.03M -$235K -32,660 -18%
1
2
3 4 5

RDY Hedge Fund Activity: Q3 2017 in Review

118 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2017, worth a combined $814M — down 24% from $1.07B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of RDY and 13 opened new positions — a net loss of 9 holders — while 41 trimmed existing stakes and 42 added.

The largest buyer was UBS Group, adding an estimated $12.1M. The largest seller was Commonwealth Bank of Australia, cutting an estimated $48.4M.

  • 118 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2017, down from 128 in Q2 2017.
  • Funds reported $814M of Dr. Reddy's Laboratories stock for Q3 2017, down 24% quarter-over-quarter.
  • 13 funds opened new Dr. Reddy's Laboratories positions in Q3 2017 and 22 closed out, a net change of -9 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2017 was UBS Group, an estimated $12.1M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2017 was Commonwealth Bank of Australia, an estimated $48.4M sold.

Based on aggregated 13F filings for Q3 2017.